Graves' Ophthalmopathy
Open Access
- 5 March 2009
- journal article
- review article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 360 (10), 994-1001
- https://doi.org/10.1056/nejmcp0806317
Abstract
A 40-year-old woman in whom Graves' disease was recently diagnosed comes for a follow-up visit. She has been taking methimazole, at a dose of 10 mg per day, and is now euthyroid, but for the past 3 months, she has had bothersome eye symptoms, including redness, tearing, grittiness, photophobia, diplopia at the extremes of gaze, and ocular pain associated with eye movements. She smokes 10 cigarettes per day. How should Graves' ophthalmopathy be managed?Keywords
This publication has 47 references indexed in Scilit:
- Graves' DiseaseThe New England Journal of Medicine, 2008
- Are There More than Antibodies to the Thyroid-Stimulating Hormone Receptor that Meet the Eye in Graves’ Disease?Endocrinology, 2006
- Current Perspective on the Pathogenesis of Graves’ Disease and OphthalmopathyEndocrine Reviews, 2003
- Pathophysiology of Graves’ Ophthalmopathy: The Cycle of DiseaseJournal of Clinical Endocrinology & Metabolism, 2003
- Thyrotropin Receptor Expression in Orbital Adipose/Connective Tissues from Patients with Thyroid-Associated OphthalmopathyThyroid®, 2002
- Management of Graves' Ophthalmopathy: Reality and PerspectivesEndocrine Reviews, 2000
- Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOLBritish Journal of Ophthalmology, 1998
- Clinical Features of Graves' Ophthalmopathy in an Incidence CohortAmerican Journal of Ophthalmology, 1996
- Natural history of thyroid associated ophthalmopathyClinical Endocrinology, 1995
- Autoantibodies to Igf-1 Binding Sites in Thyroid Associated OphthalmopathyAutoimmunity, 1993